NU 6102 yielded GI50 values of 5.7±0.4 μM in HCT116 cells and 13.3±3.4 μM in HT29 cells after incubation for 72 h. In asynchronously cycling HCT-116 TICRR-mClover cells, treatment at 20uM for 2 h decreased bulk TICRR protein levels, assessed by capillary electrophoresis. In primary cells derived from late-stage HGSC clinical samples and cell line models, NU 6102 showed no activity in the live cell viability readout (IC50 > 10 μM). [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Growth inhibition in HCT116 cells
Cell-based study · HCT116 [1]
HCT116 cells were incubated with the compound for 72 h. The GI50 was 5.7±0.4 μM.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.001–100 μM
- Exposure duration
- 72 h
- Method
- incubated
- Vehicle
- DMSO with a final DMSO concentration of 1% (v/v)
Methods and source locations
Compound reported in the paper: NU 6102
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Cell growth inhibition assays (S12, S13, S14, S15); Table 2 (T2.h1, T2.r11)
50% growth inhibition (GI50): 50% growth inhibition (GI50); comparator: cells exposed to 1% (v/v) DMSO — Materials and methods > Cell growth inhibition assays (S15); Table 2 (T2.h1, T2.r11)
TICRR protein decrease in asynchronously cycling cells
Cell-based study · asynchronously cycling HCT-116 TICRR-mClover cells [2]
Asynchronously cycling HCT-116 TICRR-mClover cells received 20uM of the compound in the culture medium for 2 h. Capillary electrophoresis showed a decrease in bulk TICRR protein levels.
Literature-Reported Treatment Conditions
- Treatment concentration
- 20uM
- Exposure duration
- 2 h
- Method
- added to the cell culture medium
- Reported limits
- Not stated in the sentences used: vehicle, control.
Methods and source locations
Compound reported in the paper: NU 6102
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
MATERIALS AND METHODS > Cell culture (S7); RESULTS > CDK1/2 inhibition promotes TICRR protein degradation during S phase (S192, S193); Figure 9. legend (S319)
TICRR protein levels by capillary electrophoresis: TICRR protein levels by capillary electrophoresis — RESULTS > CDK1/2 inhibition promotes TICRR protein degradation during S phase (S192, S193)
Viability assessment in HGSC models
Cell-based study · primary cells derived from late-stage HGSC clinical samples and cell line models [3]
The compound was evaluated for live cell viability in primary cells derived from late-stage HGSC clinical samples and cell line models. It showed no activity (IC50 > 10 μM).
Literature-Reported Treatment Conditions
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: NU 6102
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Compounds, cell culture and cell viability assays (S44, S48); Results > Validation of predicted HGSC-specific therapeutics (S113, S117, S118)
live cell viability: live cell viability; comparator: vehicle control and Staurosporine positive control — Methods > Compounds, cell culture and cell viability assays (S44); Results > Validation of predicted HGSC-specific therapeutics (S118)
Growth inhibition in HT29 cells
Cell-based study · HT29 [1]
HT29 cells were incubated with the compound for 72 h. The GI50 was 13.3±3.4 μM.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.001–100 μM
- Exposure duration
- 72 h
- Method
- incubated
- Vehicle
- DMSO with a final DMSO concentration of 1% (v/v)
Methods and source locations
Compound reported in the paper: NU 6102
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Cell growth inhibition assays (S12, S13, S14, S15); Table 2 (T2.h1, T2.r11)
50% growth inhibition (GI50): 50% growth inhibition (GI50); comparator: cells exposed to 1% (v/v) DMSO — Materials and methods > Cell growth inhibition assays (S15); Table 2 (T2.h1, T2.r11)